ADXSAdvaxis, Inc.

$0.6036
$0.0336
(5.89%)
Today
Updated: 01:47 PM EST
Mkt Cap$25.73M
Vol13,591.00
50

Neutral Sentiment

How do you feel about ADXS?

About

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Ayala Pharmaceuticals Inc.?
What is the 52-week high for Ayala Pharmaceuticals Inc.?
What is the 52-week low for Ayala Pharmaceuticals Inc.?
What is Ayala Pharmaceuticals Inc. stock price today?
What was Ayala Pharmaceuticals Inc. stock price yesterday?
What is the 50-day moving average of Ayala Pharmaceuticals Inc.?

Latest ADXS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.